The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Letarte, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Letarte, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

The Journal of Immunology, Vol 156, Issue 2 564-573, Copyright © 1996 by American Association of Immunologists


ARTICLES

Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells

H Zhang, AR Shaw, A Mak and M Letarte
Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Canada.

Endoglin was first identified on a cell line derived from pre-B acute lymphoblastic leukemia. This 180-kDa homodimeric glycoprotein was then shown to be primarily expressed on endothelial cells and to bind the beta 1 and beta 3 isoforms of TGF-beta with high affinity. We now demonstrate that pre-B leukemic cells express a functional TGF-beta 1 receptor complex. The levels of mRNA for these receptors and for TGF- beta 1 were quantitated by PCR. HOON, G2, and NALM-6 cell lines express similar levels of mRNA for TGF-beta 1 and for TGF-beta receptor I (R-I) and receptor II (R-II). HOON cells express ten times more endoglin than G2 and NALM-6 cells, whereas all three cell lines have low levels of betaglycan relative to other cell types. The receptors were identified by affinity labeling with 125I-labeled TGF-beta 1, chemical cross- linking, and specific immunoprecipitation. Endoglin, R-II, and R-I were co-precipitated by Abs to either endoglin or R-II, indicating that these proteins are forming a receptor complex on leukemic cells; no betaglycan could be immunoprecipitated. The receptor complex is functional, as demonstrated by inhibition of proliferation of HOON cells (80%) and NALM-6 cells (60%) with 25 pM TGF-beta 1. Furthermore, the motility of HOON and NALM-6 cells on immobilized fibronectin, which appears to be alpha 4 beta 1-integrin mediated, was stimulated two- to threefold by TGF-beta 1. These results suggest that active TGF-beta 1 produced in the bone marrow microenvironment might stimulate the motility of normal pre-B cells and the peripheral dissemination of leukemic pre-B cells.


This article has been cited by other articles:


Home page
GutHome page
T Gebhardt, A Lorentz, F Detmer, C Trautwein, H Bektas, M P Manns, and S C Bischoff
Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor {beta}1
Gut, July 1, 2005; 54(7): 928 - 934.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. B. Schmidt-Weber, M. Letarte, S. Kunzmann, B. Ruckert, C. Bernabeu, and K. Blaser
TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin
Int. Immunol., July 1, 2005; 17(7): 921 - 930.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Lux, C. J. Gallione, and D. A. Marchuk
Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms
Hum. Mol. Genet., March 22, 2000; 9(5): 745 - 755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.